MedPath

SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran
Ownership
Private
Established
1961-01-01
Employees
-
Market Cap
-
Website
http://www.sbmu.ac.ir/

Oat Bran and Plasma Lipid and Fecal Bacteria in Coronary Artery Disease Patients

Not Applicable
Not yet recruiting
Conditions
Coronary Arterial Disease (CAD)
First Posted Date
2024-12-24
Last Posted Date
2024-12-24
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
32
Registration Number
NCT06747234
Locations
🇮🇷

Shahid Modarres Hospital, Tehran, Iran, Islamic Republic of

Ginger and Plasma Cholesterol Efflux Capacity

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2024-10-29
Last Posted Date
2025-04-09
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
35
Registration Number
NCT06662695
Locations
🇮🇷

Nutrition Clinic located in the Faculty of Nutrition Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

The Effect of Telenursing on Self-efficacy and Treatment Adherence in Children With Cystic Fibrosis

Not Applicable
Completed
Conditions
Cystic Fibrosis in Children
First Posted Date
2024-10-28
Last Posted Date
2024-10-30
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
50
Registration Number
NCT06660745
Locations
🇮🇷

Mofid Children Hospital, Tehran, Iran, Islamic Republic of

Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL

Phase 1
Not yet recruiting
Conditions
Acute Lymphocytic Leukemia in Relapse
Interventions
Biological: anti CD19 CAR NK cells
First Posted Date
2024-10-08
Last Posted Date
2024-10-08
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
10
Registration Number
NCT06631040
Locations
🇮🇷

Shahid Ghazi Hospital, Tabriz university of medical sciences, Tabriz, Iran, Islamic Republic of

Naringenin Supplementation in Bone Fracture Patients

Not Applicable
Recruiting
Conditions
Bone Fractures
Interventions
Dietary Supplement: The daily ingestion of capsules containing naringenin
Dietary Supplement: Placebo
First Posted Date
2024-09-25
Last Posted Date
2025-05-13
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
70
Registration Number
NCT06612762
Locations
🇮🇷

Ayatollah Taleghani Educational Hospital, Tehran, Iran, Islamic Republic of

Effectiveness of Thyme in the Management of Clinical Symptoms in Patients with Irritable Bowel Syndrome

Not Applicable
Not yet recruiting
Conditions
Irritable Bowel Syndrome (IBS)
Interventions
Dietary Supplement: Thyme extract
Other: Placebo
First Posted Date
2024-09-24
Last Posted Date
2024-09-24
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
52
Registration Number
NCT06609746

Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder

Not Applicable
Completed
Conditions
Generalized Anxiety Disorder
Interventions
Device: EEG Neurofeedback
First Posted Date
2024-04-12
Last Posted Date
2024-04-12
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
40
Registration Number
NCT06361953
Locations
🇮🇷

Shahid Beheshti University of Medical Science, Tehran, Iran, Islamic Republic of

Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma

Phase 1
Not yet recruiting
Conditions
Multiple Myeloma, Refractory
Interventions
Biological: Anti-BCMA CAR-NK
First Posted Date
2024-02-05
Last Posted Date
2024-03-06
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
10
Registration Number
NCT06242249
Locations
🇮🇷

Shariati Hospital, Tehran, Iran, Islamic Republic of

Topical Statin Eye Drop in the Management of the Dry Eye

Phase 1
Active, not recruiting
Conditions
Dry Eye Disease
Interventions
Drug: Statin eye drop
Drug: Placebo
First Posted Date
2024-01-17
Last Posted Date
2024-01-17
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
20
Registration Number
NCT06208384
Locations
🇮🇷

Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Empagliflozin in Heart Failure Dialysis Patients

Not Applicable
Recruiting
Conditions
Hemodialysis
Heart Failure
Interventions
First Posted Date
2023-08-01
Last Posted Date
2024-05-30
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
15
Registration Number
NCT05967156
Locations
🇮🇷

Nooshin Dalili, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath